We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
MassivEV EV Purification Column PS
Fujifilm Wako has developed the MassivEV EV Purification Column PS, which utilizes our proprietary EV isolation and purification technology known as the PS affinity method1). Used in conjunction with the specialized MassivEV Purification Buffer Set (Catalog ID 295-96601), this system enables convenient isolation and purification of EVs, including exosomes, from liter-scale cell culture supernatants.
About commercial or for-profit purposes
Please use this product for research purposes only. If you wish to use it for commercial or for-profit purposes, please contact Fujifilm Wako at wkuslabchem@fujifilm.com.
for Genetic Research
Manufacturer: | FUJIFILM Wako Pure Chemical Corporation |
Alias: | MassivEV Exosome Purification Column PS |
Features
- High-purity EVs can be efficiently isolated and purified from large volumes of cell culture supernatants (from 10 mL to several liters)
- Eliminates the need for expensive equipment like tangential flow filtration (TFF) systems. *Only a peristaltic pump is required.
Made by FUJIFILM Wako Pure Chemical Corporation and distributed by FUJIFILM Irvine Scientific.
- For research use only. Not for use in diagnostic procedures.
- Product content may differ from the actual image due to minor specification changes etc.
- If the revision of product standards and packaging standards has been made, there is a case where the actual product specifications and images are different.
References
- Nakai, W. et al.: Sci. Rep. 6(1), 1(2016).
A novel affinity-based method for the isolation of highly purified extracellular vesicles - Mansouri, N. et al.: JCI insight, 4(21), e128060(2019).
Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes - Angioni, R. et al.: Int. J. Mol. Sci., 21(22), 8874(2020).
Administration of human MSC-derived extracellular vesicles for the treatment of primary sclerosing cholangitis: preclinical data in MDR2 knockout mice - Perets, N. et al.: Mol. Autism, 11(1), 65(2020).
Exosomes derived from mesenchymal stem cells improved core symptoms of genetically modified mouse model of autism Shank3B - Théry, C. et al.: J. Extracell. Vesicles, 7(1), 1535750(2018).
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines